Litcius/Paper detail

Pegylated LyeTx I-b peptide is effective against carbapenem-resistant Acinetobacter baumannii in an in vivo model of pneumonia and shows reduced toxicity

Júlio César Moreira Brito, William Gustavo Lima, Jarbas M. Resende, Débora Cristina Sampaio de Assis, Daiane Boff, Valbert Nascimento Cardoso, Flávio A. Amaral, Elaine M. Souza‐Fagundes, Simone Odília Antunes Fernandes, Maria Elena de Lima

2021International Journal of Pharmaceutics17 citationsDOI

Topics & Concepts

Acinetobacter baumanniiAntimicrobialMicrobiologyToxicityContext (archaeology)In vivoMultiple drug resistanceAntimicrobial peptidesHemolysisPharmacologyAntibioticsBiologyChemistryBacteriaImmunologyPseudomonas aeruginosaBiotechnologyOrganic chemistryGeneticsPaleontologyAntimicrobial Peptides and ActivitiesBiochemical and Structural CharacterizationAntibiotic Resistance in Bacteria
Pegylated LyeTx I-b peptide is effective against carbapenem-resistant Acinetobacter baumannii in an in vivo model of pneumonia and shows reduced toxicity | Litcius